UBS’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.91M Buy
41,300
+38,700
+1,488% +$2.56M ﹤0.01% 2556
2014
Q2
$147K Sell
2,600
-29,800
-92% -$1.57M ﹤0.01% 5506
2014
Q1
$1.7M Sell
32,400
-11,700
-27% -$582K ﹤0.01% 2933
2013
Q4
$2.1M Buy
44,100
+40,000
+976% +$1.85M ﹤0.01% 2746
2013
Q3
$175K Sell
4,100
-6,200
-60% -$242K ﹤0.01% 5348
2013
Q2
$371K Buy
+10,300
New +$398K ﹤0.01% 4397

Other funds holding HCA

UBS's HCA Position: Q3 2014 in Review

UBS increased its HCA Healthcare (HCA) stake by 1.8% in Q3 2014, buying an estimated $474K and bringing the position to 409,787 shares worth $28.9M. The position accounts for 0.02% of the portfolio, ranked #740.

UBS first reported a position in HCA in Q2 2013 and has held it in 6 quarters since. The position peaked at $68.5M in Q1 2014. 506 funds tracked by Wall St. Rank hold HCA as of Q3 2014.

  • UBS held 409,787 shares of HCA Healthcare worth $28.9M as of Q3 2014.
  • UBS bought 7,174 HCA Healthcare shares in Q3 2014, an estimated $474K.
  • HCA Healthcare made up 0.02% of UBS's portfolio in Q3 2014, its #740 holding.
  • UBS first reported a position in HCA Healthcare in Q2 2013 and has held it in 6 quarters since.
  • UBS's HCA Healthcare position peaked at $68.5M in Q1 2014.
  • 506 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.